Vanguard Group’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $15.6M | Sell |
831,379
-90,025
| -10% | -$1.36M | ﹤0.01% | 2738 |
|
|
2025
Q3 | $11.8M | Buy |
921,404
+1,849
| +0.2% | +$27.7K | ﹤0.01% | 2889 |
|
|
2025
Q2 | $15.4M | Sell |
919,555
-13,431
| -1% | -$181K | ﹤0.01% | 2681 |
|
|
2025
Q1 | $11.9M | Sell |
932,986
-19,678
| -2% | -$316K | ﹤0.01% | 2751 |
|
|
2024
Q4 | $16.8M | Sell |
952,664
-33,706
| -3% | -$639K | ﹤0.01% | 2667 |
|
|
2024
Q3 | $22.5M | Buy |
986,370
+21,272
| +2% | +$481K | ﹤0.01% | 2535 |
|
|
2024
Q2 | $22.1M | Buy |
965,098
+20,103
| +2% | +$620K | ﹤0.01% | 2519 |
|
|
2024
Q1 | $37.4M | Buy |
944,995
+10,351
| +1% | +$409K | ﹤0.01% | 2294 |
|
|
2023
Q4 | $37M | Sell |
934,644
-46,049
| -5% | -$1.93M | ﹤0.01% | 2312 |
|
|
2023
Q3 | $43.5M | Buy |
980,693
+10,454
| +1% | +$456K | ﹤0.01% | 2197 |
|
|
2023
Q2 | $42.2M | Buy |
970,239
+110,841
| +13% | +$4.87M | ﹤0.01% | 2259 |
|
|
2023
Q1 | $37.4M | Sell |
859,398
-1,029
| -0.1% | -$45.4K | ﹤0.01% | 2303 |
|
|
2022
Q4 | $32.1M | Buy |
860,427
+9,174
| +1% | +$355K | ﹤0.01% | 2388 |
|
|
2022
Q3 | $33.9M | Buy |
851,253
+6,494
| +0.8% | +$240K | ﹤0.01% | 2376 |
|
|
2022
Q2 | $32.3M | Sell |
844,759
-2,275
| -0.3% | -$82.3K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $33.6M | Sell |
847,034
-6,103
| -0.7% | -$239K | ﹤0.01% | 2516 |
|
|
2021
Q4 | $35.4M | Sell |
853,137
-20,123
| -2% | -$875K | ﹤0.01% | 2541 |
|
|
2021
Q3 | $36.8M | Sell |
873,260
-7,765
| -0.9% | -$391K | ﹤0.01% | 2528 |
|
|
2021
Q2 | $40.4M | Buy |
881,025
+127,129
| +17% | +$6.05M | ﹤0.01% | 2480 |
|
|
2021
Q1 | $35.3M | Buy |
753,896
+23,128
| +3% | +$1.12M | ﹤0.01% | 2493 |
|
|
2020
Q4 | $31.2M | Buy |
730,768
+24,537
| +3% | +$1.26M | ﹤0.01% | 2427 |
|
|
2020
Q3 | $34.8M | Sell |
706,231
-873
| -0.1% | -$48.3K | ﹤0.01% | 2201 |
|
|
2020
Q2 | $41.2M | Buy |
707,104
+23,293
| +3% | +$1.23M | ﹤0.01% | 2095 |
|
|
2020
Q1 | $31.1M | Buy |
683,811
+11,080
| +2% | +$666K | ﹤0.01% | 2075 |
|
|
2019
Q4 | $44.4M | Buy |
672,731
+56,933
| +9% | +$3.48M | ﹤0.01% | 2173 |
|
|
2019
Q3 | $35.6M | Buy |
615,798
+52,847
| +9% | +$3.27M | ﹤0.01% | 2230 |
|
|
2019
Q2 | $32.4M | Buy |
562,951
+52,656
| +10% | +$2.44M | ﹤0.01% | 2308 |
|
|
2019
Q1 | $19.7M | Buy |
510,295
+6,648
| +1% | +$260K | ﹤0.01% | 2512 |
|
|
2018
Q4 | $19.2M | Buy |
503,647
+5,946
| +1% | +$228K | ﹤0.01% | 2458 |
|
|
2018
Q3 | $19.2M | Buy |
497,701
+12,448
| +3% | +$472K | ﹤0.01% | 2595 |
|
|
2018
Q2 | $18.1M | Buy |
485,253
+159,492
| +49% | +$5.56M | ﹤0.01% | 2603 |
|
|
2018
Q1 | $9.53M | Buy |
325,761
+8,080
| +3% | +$271K | ﹤0.01% | 2847 |
|
|
2017
Q4 | $11.8M | Buy |
317,681
+35,194
| +12% | +$1.25M | ﹤0.01% | 2739 |
|
|
2017
Q3 | $10.7M | Buy |
282,487
+22,477
| +9% | +$706K | ﹤0.01% | 2778 |
|
|
2017
Q2 | $6.99M | Buy |
260,010
+7,177
| +3% | +$175K | ﹤0.01% | 2944 |
|
|
2017
Q1 | $4.98M | Sell |
252,833
-78,183
| -24% | -$1.45M | ﹤0.01% | 3052 |
|
|
2016
Q4 | $6.29M | Sell |
331,016
-26,467
| -7% | -$437K | ﹤0.01% | 2955 |
|
|
2016
Q3 | $5.82M | Buy |
357,483
+453
| +0.1% | +$7.11K | ﹤0.01% | 2929 |
|
|
2016
Q2 | $4.89M | Buy |
357,030
+108,751
| +44% | +$1.53M | ﹤0.01% | 2992 |
|
|
2016
Q1 | $3.86M | Buy |
248,279
+5,141
| +2% | +$75.4K | ﹤0.01% | 3102 |
|
|
2015
Q4 | $3.9M | Sell |
243,138
-320
| -0.1% | -$4.86K | ﹤0.01% | 3096 |
|
|
2015
Q3 | $2.91M | Buy |
243,458
+11,948
| +5% | +$159K | ﹤0.01% | 3208 |
|
|
2015
Q2 | $3.29M | Buy |
231,510
+5,094
| +2% | +$72.2K | ﹤0.01% | 3200 |
|
|
2015
Q1 | $3.26M | Buy |
226,416
+5,645
| +3% | +$79.8K | ﹤0.01% | 3201 |
|
|
2014
Q4 | $3.09M | Buy |
220,771
+2,254
| +1% | +$33.1K | ﹤0.01% | 3114 |
|
|
2014
Q3 | $2.84M | Buy |
218,517
+5,091
| +2% | +$70K | ﹤0.01% | 3119 |
|
|
2014
Q2 | $2.99M | Buy |
213,426
+4,196
| +2% | +$63.1K | ﹤0.01% | 3078 |
|
|
2014
Q1 | $3.47M | Buy |
209,230
+5,581
| +3% | +$93.5K | ﹤0.01% | 2995 |
|
|
2013
Q4 | $3.83M | Buy |
203,649
+9,549
| +5% | +$168K | ﹤0.01% | 2927 |
|
|
2013
Q3 | $3.65M | Buy |
194,100
+5,780
| +3% | +$99.3K | ﹤0.01% | 2898 |
|
|
2013
Q2 | $3.39M | Buy |
+188,320
| New | +$3.01M | ﹤0.01% | 2869 |
|
Other funds holding NRC
QI
Vanguard Group's NRC Position: Q4 2025 in Review
Vanguard Group reduced its NRC Health Common Stock (NRC) stake by 9.8% in Q4 2025, selling an estimated $1.36M and leaving 831,379 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2738.
Vanguard Group first reported a position in NRC in Q2 2013 and has held it in 51 quarters since. The position peaked at $44.4M in Q4 2019. 117 funds tracked by Wall St. Rank hold NRC as of Q4 2025.
- Vanguard Group held 831,379 shares of NRC Health Common Stock worth $15.6M as of Q4 2025.
- Vanguard Group sold 90,025 NRC Health Common Stock shares in Q4 2025, an estimated $1.36M.
- NRC Health Common Stock made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2738 holding.
- Vanguard Group first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's NRC Health Common Stock position peaked at $44.4M in Q4 2019.
- 117 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.